Introduction
In Drosophila, the larval somatic (skeletal) musculature arises from the fusion of two distinct types of myoblasts, the founders and fusion-competent cells (for review see Beckett and Baylies, 2006) . Subsequent differentiation programs, including activation of muscle-specifi c gene expression and asymmetrical cell fusion between the differentially marked founders and fusion-competent myoblasts, are required for the generation of syncytial muscle fi bers. Maturation of these syncytia into functional muscle fi bers involve additional events, including pathfi nding processes and the formation of attachments to the tendon cells, as well as the establishment of neuromuscular junctions (for review see Volk, 1999; Schnorrer and Dickson, 2004) . The functional characterization of integrins and downstream effectors of integrin signals has underscored the importance of this pathway in establishing muscle attachment sites (for review see Bokel and Brown, 2002) . However, the molecular basis for many other aspects of morphogenesis and maintenance of the mature muscles is still poorly defi ned.
Herein, we present a functional characterization of Drosophila mind bomb2 (mib2), which shares structural similarities with its paralogue mib1. Unlike mib1, mib2 is prominently expressed in muscle progenitors and differentiated musculatures. We show that loss of mib2 activity leads to muscle detachment and massive muscle degeneration. We also demonstrate that mib2 functions in a novel integrin-and Notch-independent manner to maintain the integrity of the mature somatic musculature.
Results and discussion
Characterization of the Drosophila mind bomb2 gene product Drosophila mind bomb2 (mib2) encodes a 1,050-amino acid protein with several notable features (Fig. 1 A) . A ZZ zinc fi nger domain within the N-terminal portion is fl anked by two regions that share homology with HERC2, a protein that may function in protein traffi cking and degradation pathways (Lehman et al., 1998; Ji et al., 1999) . The ZZ domain, characterized by Cys-X 2 -Cys and Asp-Tyr-Asp-Leu motifs, is found in a small number of proteins, including some transcriptional adaptor proteins and Dystrophin/ Utrophin, and is implicated in protein-protein interactions (Ponting et al., 1996) . Following the ZZ and HERC2-like domains is a repeated sequence that is specifi c to Mib proteins. Eight Ankyrin repeats are in the middle portion of the protein and two RING fi ngers at the C-terminal end. Ankyrin repeats are present in a vast number of proteins and their role in protein-protein interactions is well documented (Sedgwick and Smerdon, 1999) , Drosophila mind bomb2 is required for maintaining muscle integrity and survival W e report that the Drosophila mind bomb2 (mib2) gene is a novel regulator of muscle development. Unlike its paralogue, mib1, zygotic expression of mib2 is restricted to somatic and visceral muscle progenitors, and their respective differentiated musculatures. We demonstrate that in embryos that lack functional Mib2, muscle detachment is observed beginning in mid stage 15 and progresses rapidly, culminating in catastrophic degeneration and loss of most somatic muscles by stage 17. Notably, the degenerating muscles are positive for apoptosis markers, and inhibition of apoptosis in muscles prevents to a signifi cant degree the muscle defects. Rescue experiments with Mib1 and Neuralized show further that these E3 ubiquitin ligases are not capable of ameliorating the muscle mutant phenotype of mib2. Our data suggest strongly that mib2 is involved in a novel Notch-and integrin-independent pathway that maintains the integrity of fully differentiated muscles and prevents their apoptotic degeneration.
while RING fi ngers proteins are known to participate in proteinprotein interactions in the ubiquitination pathway (Joazeiro and Weissman, 2000) . The presence of these various domains suggests that Mib2 functions as an adaptor-type of protein and/or as a component of a ubiquitination pathway.
The Mib2 protein is conserved during evolution. Drosophila Mib2 and its murine orthologue display a similar structural organization and considerable degree of amino acid conservation within all the aforementioned domains (Fig. 1 A; and Fig. S1 , available at http://www.jcb.org/cgi/content/full/jcb.200708135/DC1). When compared with Mib2 proteins across species, Drosophila Mib1, an E3 ubiquitin ligase that has been shown to be important in Notch signaling (Itoh et al., 2003; Lai et al., 2005; Le Borgne et al., 2005; Pitsouli and Delidakis, 2005; Wang and Struhl, 2005) , shows a lower level of homology in most of these domains, indicating that Mib2 is a paralogue of Mib1. In addition, the Mib2 proteins have only two RING fi nger domains while the Mib1 proteins have three.
mib2 is highly expressed in visceral and somatic mesodermal cells
Maternally derived mib2 transcripts are detected prominently in the fertilized egg (Fig. 1 B) . Zygotic expression is fi rst observed at low levels panmesodermally, and beginning at stage 11, high levels of expression appear in progenitors of somatic and visceral muscles (Fig. 1 C) and persist in the differentiated muscles of late stage embryos (Fig. 1, D and E; and unpublished data) . mib2 is not detectable in cardiomyocytes. Co-localization of mib2 RNA (cytoplasmic) and LacZ protein (nuclear) in embryos derived from the rP298 enhancer trap line (Nose et al., 1998) , which carries a P-LacZ insertion within the dumbfounded (duf) gene that is active in all founders (Ruiz-Gomez et al., 2000), confi rmed that mib2 expression is specifi c for founder myoblasts (Fig. 1 F) . Accordingly, mib2 is not detected in Lame duck (Lmd)-positive fusioncompetent cells (Duan et al., 2001 ; Fig. 1 G) . Mib2 protein expression is identical to that of mib2 mRNA and appears to be in the cytoplasm of founder cells (Fig. 1, H-J) . In contrast, mib1 expression is not detectable in mesodermal cells (unpublished data).
Identifi cation of mib2 mutant alleles
Genetic and molecular analysis in the vicinity of the 37B10 locus identifi ed the lethal complementation group l(2)37Be as a likely candidate for mib2 (CG17492; see Materials and methods). We obtained the two extant alleles, l(2)37Be 1 and l(2)37Be 4 , for further analysis. Sequence analysis of the protein-coding exons showed that the mib2 gene on the l(2)37Be 1 mutant chromosome contains a nucleotide change (C to T) that converts Gln 377 to a nonsense codon ( Fig. 1 A and Fig. S1 ). On the l(2)37Be 4 chromosome, a two-base pair deletion converts Asn 587 to a Thr, which is then followed by a nonsense codon. As shown below, expression of wildtype mib2 in l (2)37Be 1 mutant embryos can rescue the observed muscle phenotype. We conclude that the l(2)37Be 1 and l(2)37Be 4 alleles correspond to bona fi de mib2 mutations and henceforth designate these alleles as mib2 1 and mib2
4
, respectively. Based upon our analysis, the mutant Mib2 1 protein lacks all Ankyrin repeats and RING fi ngers while the mutant Mib2 4 protein lacks the RING fi ngers but retains four out of the predicted eight Ankyrin repeats.
mib2 mutant embryos exhibit detached muscles during later stages of embryogenesis
To assess the consequence of loss of mib2 function on muscle development, we stained wild-type and mutant embryos with an antibody against Myosin to visualize the muscle pattern. We focused more on the mib2 1 allele because the molecular nature of this mutation suggests that it is a stronger mutant allele. As compared with wild-type embryos, stage 15 mutant embryos (derived from mib2 1 germline clones and zygotically mib2 1 / Df(2L)TW130, termed "mib2 1 m&z"), which lack both maternal and zygotic mib2 activity, have a well-developed somatic musculature, although a very limited number of detached muscles can already be detected (compare Fig. 2 A with Fig. 2 D) . At stage 16, the mutant embryos exhibit a highly deranged muscle pattern that is characterized by a massive number of detached muscles (Fig. 2 B) . Many of the rounded muscles have become smaller, followed by rapid muscle degeneration. Consequently, in stage 17 mutant embryos, normal somatic muscles are absent and the size of the rounded muscles decreases dramatically (Fig. 2 C) . We observed the same types of muscle deterioration with mib2 4 mutant embryos that are null for both maternal and zygotic mib2 activity (unpublished data). Unlike the somatic muscles, the midgut muscles do not disintegrate in mib2 mutant embryos; however, the incompletely constricted midgut of these embryos suggests that mib2 also plays a role in visceral muscles (Fig. S3 , A and B; available at http://www.jcb.org/cgi/content/ full/jcb.200708135/DC1). Cardiac morphology is not affected, as predicted from the absence of mib2 expression in myocardial cells (see Fig. 5 F) . Embryos that lack only zygotic mib2 function and homozygous defi ciency embryos show similar somatic muscle and gut defects as those derived from germ line clones, although the defects are delayed and less severe (see Fig. 4 ; and unpublished data). Previous CG17492/mib2 knockdown by RNAi injections also caused some muscle detachments (Estrada et al., 2006) . To analyze the temporal progression and cause of the observed muscle phenotype, we recombined P5053A-Gal4, which is a common marker for muscle 12 (or VL1) development (Ritzenthaler et al., 2000; Swan et al., 2004) , and UAS-LacZ onto the mib2 1 chromosome. Wild-type and mutant embryos were double-labeled for Tropomyosin and LacZ expression. At late stage 14, the somatic musculature of mib2 1 mutant (m&z) embryos, including muscle 12, which is in the fi nal stages of establishing its normal attachments, looks normal (Fig. 2 E) . A low degree of muscle detachment becomes detectable at stage 15, although muscle 12 does not seem to be affected immediately, suggesting some differences in susceptibility to loss of mib2 function among the various muscles (Fig. 2 F) . However, massive muscle detachments and degeneration, which include muscle 12, occur by stage 16 (Fig. 2, G and H) . In the aggregate, this analysis indicates that mib2 function is not needed for the formation of somatic muscles and their initial attachment to tendon cells, but rather it is required at late embryogenesis for maintaining the attachments and the integrity of the mature musculature.
Loss of mib2 function does not interfere with the localization of known muscle attachment components
Because of the muscle detachment phenotype, we examined whether loss of mib2 function disrupts the localization of integrin signaling components that are known to establish stable muscle/tendon attachments (for review see Bokel and Brown, 2002) . In mib2 1 (m&z) embryos, α PS2 integrin localizes normally to the attachment sites within the tips of muscle 12 before and during the early stages of their detachment (compare Fig. 3 , A and B with Fig. 3 D) . Hence, the gradual disappearance of localized α PS2 integrin during later stages (Fig. 3 C) is presumably a consequence of the muscle detachments and deterioration rather than a cause of the detachment. Likewise, all other integrin pathway components examined, including Talin (Fig. 3, E and F) , Pinch (not depicted), ILK (Fig. 3, G and H) , and Tyr 397 -phosphorylated FAK (Fig. S3, C and D) are initially localized normally within the muscle ends near the attachment sites in the absence of mib2 activity. Several components on the epidermal side of the attachments were also unaffected (unpublished data). These observations argue against a function of mib2 in establishing stable muscle attachments via integrin signaling components unless there is a yet unknown parallel pathway to ILK that is affected.
Absence of mib2 function triggers apoptosis in muscles
As shown in Fig. 4 A, Mef2-positive nuclei are still present in the large rounded muscles of zygotic (z) mib2 1 mutant embryos at stage 16, whereas they are absent in the rounded muscles that are severely decreased in size. Because cell shrinkage and chromatin deterioration are hallmarks of apoptosis, we used TUNEL staining to detect apoptotic cells in mib2 mutant embryos. Indeed, the detaching muscles in mib2 1 (z) embryos are positive for the apoptotic marker (Fig. 4 B) , whereas heterozygous control embryos only show apoptotic signals in the CNS and other nonmuscle tissues (Fig. 4 C) . Of note, the detached muscles in myospheroid (mys) mutant embryos, which lack functional β-integrin at their attachment sites, do not show any signifi cant apoptotic signals and do not shrink, indicating that apoptosis is not an automatic consequence of muscle detachment (Fig. 4 D) . Hence, we propose that the muscle detachment in mib2 mutants is a consequence of apoptotic events in these muscles.
To test this proposal further, we blocked apoptosis through forced expression of the caspase inhibitor p35 in muscle founders and their derived muscles. Blocking apoptosis in muscles of mib2 1 (z) mutant embryos leads to a signifi cant reduction of muscle detachment and deterioration at early stage 16 (compare Fig. 4 F with Fig. 4 B; no effects are seen with analogous expression of p35 in a wild-type background [ Fig. 4 E] ). At late stage 16, some muscle degeneration still occurs in the p35-overexpressing mutant embryos, as evidenced by the slightly larger number of rounded muscles with decreased sizes and missing muscle fi bers, although it is much less severe than in mib2 1 (z) mutants without blocked apoptosis (Fig. 4 G) . A large number of muscle fi bers are still present at stage 17 in these apoptosisblocked mib2 1 (z) mutant embryos (unpublished data). Notably, the muscle degeneration phenotype is rescued in mib2 1 (z) Figure 4 . mib2 activity is required for preventing apoptosis of somatic muscles. In all panels, muscles were labeled with anti-Tropomyosin (red mutant embryos that are also homozygous for Df3R)H99, which deletes the apoptosis inducers reaper, hid, and grim, (Fig. 4 H) . In this background the majority of the muscles appear normal until at least late stage 16, although we do not know whether they change their morphology after cuticle formation. Together, these observations suggest that muscle detachment and degeneration in mib2 mutants are largely a consequence of triggered apoptosis.
Ubiquitin ligases in the Notch pathway cannot substitute for Mib2 during muscle development
Because RING fi ngers are implicated in protein ubiquitination, we sought to test whether the RING fi ngers of Mib2 are required for its activity and whether Mib1 and Neuralized (Neur), E3 ubiquitin ligases that have been shown to be modulators of the Notch pathway by ubiquitinating Delta (Lai and Rubin, 2001; Pavlopoulos et al., 2001; Lai et al., 2005; Le Borgne et al., 2005; Pitsouli and Delidakis, 2005; Wang and Struhl, 2005) , could substitute for Mib2. Overexpression of full-length Mib2 in muscle founders and the derived muscles of wild-type embryos does not affect the pattern and stability of the muscles, although there is an increased number of unfused myoblasts at late stages (Fig. 5 A) . In the mib2 1 mutant background, forced expression of full-length Mib2 leads to essentially complete rescue of the muscle detachment and deterioration phenotype (compare Fig. 5 B with Fig. 5 D) , although an excessive number of unfused myoblasts is also evident. Notably, forced expression of a Mib2 version lacking both RING fi ngers (Mib2 ∆RF ; see Fig. 1 A) in the mutant background also allowed a significant, albeit incomplete, rescue of the muscle defects. In these embryos there is only occasional detachment of muscles and very few signs of apoptotic decay, although the muscles sometimes appear shorter and thicker as compared with normal muscles (compare Fig. 5 C with Fig. 5, A and D) . Analogous overexpression of this mutated Mib2 version in a wild-type background does not have any effects on muscles (unpublished data). Based upon the signifi cant degree of rescue with Mib ∆RF , we conclude that the RING fi ngers have a less prominent role in promoting muscle integrity as compared with the other domains, and that ubiquitination may not be the main activity of Mib2 that is required for muscle development.
In sharp contrast to full-length Mib2 and Mib2 ∆RF , Mib1 and Neur are not able to confer any rescuing activity under similar experimental conditions (compare Fig. 5 , E and F with Fig. 5 D) , suggesting that Mib2 possesses important targets that are different from those of Mib1 and Neur, and that blocked Notch signaling is not the cause of the observed muscle defects in mib2 mutant embryos. This latter point is underscored by our results from experiments with the N ts allele, which never yield any embryos with muscle phenotypes that are similar to those of mib2 mutants (unpublished data; see also Fuerstenberg and Giniger, 1998) . However, we do not exclude the possibility that Mib2 can act in the Notch pathway in other contexts, such as in post-embryonic tissues, which we have not yet examined. It has been shown in cell culture that vertebrate Mib2 is capable of ubiquitinating Delta and Jagged, and Mib2 was also identifi ed as a binding partner of Drosophila Delta in yeast two-hybrid screenings (Formstecher et al., 2005; Koo et al., 2005; Takeuchi et al., 2005; Zhang et al., 2006) . In summary, Mib2 appears to have a unique and Notchindependent role in "protecting" differentiated body wall muscles from entering apoptosis, undergoing detachment, and being subject to degradation. We speculate that Mib2 is required in a yet undefi ned pathway for the establishment of specifi c functional features of the sarcomeres or other structures of the myofi bers. In this context, it is interesting to note that mouse Mib2 (also known as skeletrophin) was identifi ed as a binding partner of α-actin and is expressed in skeletal muscles (Takeuchi et al., 2003) . The disruption of these unknown structural and functional features in the absence of mib2 activity could become detrimental upon stimulation of contractility and trigger entry into apoptosis. Apoptotic degradation of multiple components of the muscle fi bers could fi rst result in detachment because the contractile force renders muscle attachment more sensitive to disruptions, and leads to the degradation of the entire syncytia. The identity of the functional target(s) of Mib2 in muscles is currently unknown, as the expression of all markers examined to date, including founder cell markers (Fig. S2 , available at http:// www.jcb.org/cgi/content/full/jcb.200708135/DC1), muscle attachment proteins (Fig. 3) , and differentiation markers ( Fig. 3 ; Fig. 4 ; and unpublished data), is unaffected in mib2 mutant embryos. Future studies, including the identifi cation of interaction partners or mutations in other genes with similar phenotypes, will help to elucidate the pathway in which Mib2 acts to protect muscle integrity. Whether this pathway is involved in preventing skeletal muscle atrophies in which caspase-3 activation contributes to the breakdown of actomyosin complexes of myofi brils (Du et al., 2004) could also be explored.
Materials and methods
Drosophila stocks mys 1 (Digan et al., 1986) , UAS-p35 (made by Bruce Hay, CalTech, Pasadena, CA; Zhou et al., 1997) , P5053A-Gal4 (Lopez, 1998) , P{neoFRT}40A (Xu and Rubin, 1993) , UAS-lacZ (Bg4-1-2; Brand and Perrimon, 1993) , CyO wg en11 -LacZ (Kassis et al., 1992) , SM6 eve-LacZ8.0 (Panzer et al., 1992) , TM2 P{lArB}C40.1S3 (Bellen et al., 1989) , Df(3R)TW130 (Wright et al., 1976) , and the alleles l(2)37Be 1 and l(2)37Be 4 (Stathakis et al., 1995) , which were induced by EMS and EMS plus γ-rays, respectively, were obtained from the Bloomington Drosophila stock center. Other fl y stocks used include: mib1 EY9780 (Pitsouli and Delidakis, 2005) , UAS-neur (Pavlopoulos et al., 2001) , UAS-mib1-3 (Wang and Struhl, 2005) , rP298-Gal4 (Menon and Chia, 2001) , and ILK-GFP (Zervas et al., 2001) .
To generate UAS-mib2 and UAS-mib2∆RF transgenic lines, we subcloned the regions coding for amino acids 1-1,050 and amino acids 1-907, respectively, from the EST clone LP14687 (obtained from the Berkeley Drosophila Genome Project/BDGP) into the pUAST vector and injected the resulting constructs into Drosophila embryos by using standard protocols. Multiple independent insertions were obtained and analyzed for each construct.
Identifi cation of mib2 mutants
The mib2 gene maps genetically at 37B10, a genomic region that was characterized genetically and molecularly in the context of the Dopa decarboxylase gene (Stathakis et al., 1995) . By comparing the data of Stathakis et al. (1995) with those from the BDGP, we determined that mib2 is uncovered by the overlapping defi ciencies Df(2L)OD15, Df(2L)hkUC1, and Df(2L)TW130 (Wright et al., 1976) . Based upon additional molecular and genetic mapping data, we identifi ed a complementation group, l(2)37Be, of originally fi ve embryonic lethal alleles as the most likely candidate for the mib2 gene (Stathakis et al., 1995; Adams et al., 2000) . The supporting evidence includes: (1) genomic rescue experiments done by Stathakis et al. (1995) with a construct, which according to our analysis only contains mib2 and a neighboring gene called catsup (l(2)37Bc), rescued the lethality of l(2)37Be and catsup mutations; and (2) one allele, l(2)37B 5 , which no longer exists, was shown to be associated with an ‫-008ف‬bp deletion of sequences that we now have identifi ed as being part of the Drosophila mib2 gene.
Sequencing of mib2 from wild-type and mutant alleles EST clone LP14687 was fully sequenced and the derived mib2 ORF was identical to that of CG17492. For allele sequencing, the alleles were balanced with a "blue balancer". Fixed embryos were stained with an antibody against β-galactosidase, and homozygous l(2)37Be 1 or l(2)37Be 4 mutant embryos were identifi ed by the absence of LacZ expression from the "blue balancer". Hand-picked embryos of the appropriate genotype were incubated in a solution of 10 mM Tris-HCl, 1 mM EDTA, 25 mM NaCl, and 200 μg/ml proteinase K. Amplifi ed products were purifi ed and subjected directly to automated sequencing. Specifi c primers were used for sequencing all exons and exon-intron boundaries. For confi rmation, the fragment that contained a sequence aberration was reamplifi ed from genomic DNA and resequenced. The mouse Mib2 sequence data are based on our sequencing of the cDNA clone IMAGE:6516763. 
Rescue (and overexpression) experiments

Generation of Drosophila Mib2 antibodies
pET30-Mib2(COOH) was generated by cloning the PCR fragment that code for amino acids 650-1,038 of Mib2 in frame with the 6xHis tag of the pET-30a vector (Novagen). The fusion protein was expressed in Escherichia coli and purifi ed with Ni 2+ -affi nity chromatography under denaturing conditions (QIAGEN). Antiserum production in guinea pigs was done by Covance Research Products and affi nity purifi cation was performed against bacterially expressed S-tag (Novagen)-Mib2 fusion protein.
In situ RNA hybridization and immunocytochemistry of whole-mount embryos The embryonic CG17492 mRNA expression was fi rst described in the BDGP in situ hybridization database (Tomancak et al., 2002) . We confi rmed and extended these expression data with the use of a digoxygeninlabeled mib2 RNA probe that was generated by using the LP14687 cDNA clone and published protocols (Tautz and Pfeifl e, 1989) . Embryos were photographed with Nomarski DIC optics on a microscope (AX70; Olympus) with a 20× Uplan Fl/0.5 NA objective and a color camera (5.0 RTV; QImaging). Images were acquired with QImaging software and processed with Adobe Photoshop.
Immunocytochemistry was performed essentially as described (Reim et al., 2003) and the TSA amplifi cation system was used as needed. Cy3 and FITC were used as fl uorochromes. Embryo stainings were analyzed on a confocal microscope (TCS-SP 4D; Leica) with a HC Plan Apo20×/0.7 NA and a HCX Plan Apo40×/0.75-1.25 NA oil objective at 20°C. Generally, Z-scans were taken at 1-to 1.5-μm steps and four to eight Z-scans were merged via maximum projection using the Leica TCS software package or Adobe Photoshop CS. Except for the fi nal adjustment of contrast and brightness with Adobe Photoshop CS, no other processing of the imaging was performed.
Antibodies were used as follows: mouse anti-βgalactosidase (1:100; developed by J. Sanes, Washington University, St. Louis. MO, and obtained through DSHB, Iowa University, Iowa City, IA), rabbit anti-β-galactosidase (1:1500; ICN), rat anti-Tropomyosin (1:50; Babraham Tech), mouse anti-Myosin (1:200; Kiehart and Feghali, 1986) ; rabbit anti-Mef2 (1:700; Bour et al., 1995) ; rat anti-αPS2 (1:10, TSA; Wilcox et al., 1981) ; rabbit and mouse anti-Talin (1:750, TSA, and 1:20, TSA, respectively; Brown et al., 2002) ; rabbit anti-Pinch (1:15,000, TSA; Clark et al., 2003) ; rabbit anti-FAK[pY397] (1:300; Biosource International); and rabbit anti-GFP (1:10,000, TSA; Molecular Probes). Biotinylated (1:200, Vector Laboratories) and fl uorescent (1:100, Jackson ImmunoResearch Laboratories) secondary antibodies were also used. The Apoptag kit (Intergen) was used for detecting apoptotic cells as described in Reim et al. (2003) . Figure S1 shows protein sequence alignment of D. mel. Mib2 with D. mel Mib1 and mouse Mib2. Figure S2 shows absence of any effects of mib2 mutation on muscle founder marker expression. Figure S3 shows gut phenotype and phospho-FAK staining in mib2 mutant embryos. Online supplemental material is available at http://www.jcb.org/cgi/content/ full/jcb.200708135/DC1.
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